Orthopediatrics (KIDS) Cash from Operations (QoQ) (2017 - 2026)
Orthopediatrics (KIDS) Cash from Operations (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Orthopediatrics | 464.46 Mn | 450.22 Mn | 43.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -131.76% |
| Dec 31, 2025 | 1,881.07% |
| Sep 30, 2025 | 94.45% |
| Jun 30, 2025 | -151.73% |
| Mar 31, 2025 | -4.24% |
| Dec 31, 2024 | 61.21% |
| Sep 30, 2024 | -68.73% |
| Jun 30, 2024 | 8.94% |
| Mar 31, 2024 | 11.31% |
| Dec 31, 2023 | 12.99% |
| Sep 30, 2023 | -98.24% |
| Jun 30, 2023 | 32.32% |
| Mar 31, 2023 | -93.39% |
| Dec 31, 2022 | 44.85% |
| Sep 30, 2022 | 25.85% |
| Jun 30, 2022 | -94.66% |
| Mar 31, 2022 | -239.84% |
| Dec 31, 2021 | -31.80% |
| Sep 30, 2021 | 89.56% |
| Jun 30, 2021 | -368.72% |